Regeneron
Trade Regeneron 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About REGN
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara.
REGN Key Statistics
Stock Snapshot
Regeneron(REGN) stock is priced at $801.01, giving the company a market capitalization of 84.19B. It carries a P/E multiple of 19.45 and pays a dividend yield of 43.3%.
On 2026-01-09, Regeneron(REGN) stock moved within a range of $800.68 to $816.99. With shares now at $801.01, the stock is trading +0.0% above its intraday low and -2.0% below the session's peak.
Trading activity shows a volume of 1.05M, compared to an average daily volume of 642.17K.
The stock's 52-week range extends from a low of $476.49 to a high of $816.99.
The stock's 52-week range extends from a low of $476.49 to a high of $816.99.
REGN News
In recent trading, shares of Regeneron Pharmaceuticals, Inc. (Symbol: REGN) have crossed above the average analyst 12-month target price of $816.30, changing ha...
Could the tide be turning for Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) after a surprising shift in analyst sentiment? As investors digest the latest upgrad...
BofA upgraded Regeneron (REGN) to Buy from Underperform with a price target of $860, up from $627. Claim 70% Off TipRanks Premium Published first on TheFly –...
Analyst ratings
70%
of 30 ratingsMore REGN News
Regeneron Pharmaceuticals (REGN), Sanofi SA (SNY) announced an update on their ongoing clinical study. Claim 70% Off TipRanks This Holiday Season Study Overvi...
The medical sector is one of the major adopters of artificial intelligence (AI), which is currently being used to synthesize new compounds for drugs and create...
Regeneron Pharmaceuticals (REGN) has drawn investor attention after its recent share price move, with the stock closing at $776.31. That shift is prompting fres...
